Feb 20, 2009
In 2004, I did some reportage for the Royal Society from their meeting on emerging viral infections. The meeting was held just after the worldwide SARS outbreak that threw nations into chaos and had the more susceptible parts of the media hyping the end of the world. Of course, SARS, an emerging pathogen, was lethal and had devastating effects on thousands of people.
Ultimately, the first SARS outbreak …
Feb 18, 2009
In the latest ezines from SpectroscopyNOW:
Magnetic drug delivery for Alzheimer’s disease – Tiny pieces of magnetite incorporated into chitosan microparticles could act as efficient drug-delivery agents for the Alzheimer’s drug tacrine. Tacrine has notoriously low oral bioavailability and unclear efficacy but this delivery approach boosts uptake.
Contrasting tumours – US scientists have successfully predicted the outcome on breast tumours in a pre-clinical study of a …
Oct 22, 2008
The marketing hype surrounding Rhodiola rosea would suggest that anyone taking it would be cured of almost any ailment and have renewed vitality. It may have some benefits, as yet unproven, but the idea that it could allow you to live long and prosper? Well, there are no peer-reviewed scientific research papers to support such claims.
…
The Scientist provides compelling print and online coverage of the latest developments in the life sciences including research, technology and business. If you are an active researcher interested in maintaining a broad view of the life sciences, grab a free subscription courtesy of Sciencebase today.
Sciencebase FAQ
Contact me